Cantor Fitzgerald Starts Cubist Pharmaceuticals (CBST) at Sell, Sees Slowing Revenue Trajectory
Tweet Send to a FriendGet Alerts CBST Hot Sheet
Price: $49.51 +1.81%
Rating Summary:
9 Buy, 7 Hold, 1 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 11 | Down: 35 | New: 23
Rating Summary:
9 Buy, 7 Hold, 1 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 11 | Down: 35 | New: 23
Trade CBST Now!
Cantor Fitzgerald initiates coverage on Cubist Pharmaceuticals (NASDAQ: CBST) with a Sell. PT $37.00.
The firmcommetns, "CBST ran up following the 2011 Adolor acquisition, but we see the company's revenue trajectory slowing in 2013 as its key revenue driver, Cubicin, matures and competitors begin to take market share. Following the recent revenue miss in 3Q:12, we think there is more downside in the story. It is evident that Cubist is in the midst of an investment phase, which is likely to hurt 2013-2014 earnings expectations."
For an analyst ratings summary and ratings history on Cubist Pharmaceuticals click here. For more ratings news on Cubist Pharmaceuticals click here.
Shares of Cubist Pharmaceuticals closed at $45.44 yesterday, with a 52 week range of $34.58-$49.86.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
The firmcommetns, "CBST ran up following the 2011 Adolor acquisition, but we see the company's revenue trajectory slowing in 2013 as its key revenue driver, Cubicin, matures and competitors begin to take market share. Following the recent revenue miss in 3Q:12, we think there is more downside in the story. It is evident that Cubist is in the midst of an investment phase, which is likely to hurt 2013-2014 earnings expectations."
For an analyst ratings summary and ratings history on Cubist Pharmaceuticals click here. For more ratings news on Cubist Pharmaceuticals click here.
Shares of Cubist Pharmaceuticals closed at $45.44 yesterday, with a 52 week range of $34.58-$49.86.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
You May Also Be Interested In
- UPDATE: Applied Materials, Inc. (AMAT) Tops Q2 EPS by 3c, Offers Guidance
- Macy's (M) Posts Q1 EPS of 55c; Comps Up 3.8%; Boosts Dividend 25%, Raises Buyback
- BofA/Merrill Lynch Starts Dangdang (DANG) at Buy
Create E-mail Alert Related Categories
Hot New Coverage, New CoverageRelated Entities
Cantor Fitzgerald, Earnings
Login with Facebook
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
